PROM1 and malignant colon neoplasm: The purpose of our study was to investigate if in vitro concentrations of EPA equal to plasma levels achievable in the human body following supplementation of the diet with 2.4 g n-3/day [30], were able to affect the differentiation status and chemosensitivity of the overall population of colon cancer cells and specifically of the CD133 (+) CLSCs.